CLDN6 and neoplasm: As shown in Fig. 4B and 4D, in the CLDN6-CAR1 NK groups, the calculated tumor volume remained relatively stable and low level, whereas in the NC and CD19-CAR NK groups, the tumor volume progressed obviously.